Illumina Current Deferred Revenue from 2010 to 2026
| ILMN Stock | USD 116.81 2.37 2.07% |
Current Deferred Revenue | First Reported 2001-03-31 | Previous Quarter 247 M | Current Value 234 M | Quarterly Volatility 88.9 M |
Check Illumina financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Illumina's main balance sheet or income statement drivers, such as Depreciation And Amortization of 284.6 M, Interest Expense of 63.2 M or Total Revenue of 4.6 B, as well as many indicators such as Price To Sales Ratio of 4.51, Dividend Yield of 0.0 or PTB Ratio of 5.48. Illumina financial statements analysis is a perfect complement when working with Illumina Valuation or Volatility modules.
Illumina | Current Deferred Revenue | Build AI portfolio with Illumina Stock |
Evaluating Illumina's Current Deferred Revenue across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Illumina's fundamental strength.
Latest Illumina's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Illumina over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Illumina's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Illumina's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Illumina Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 161,682,235 | |
| Geometric Mean | 125,793,541 | |
| Coefficient Of Variation | 57.98 | |
| Mean Deviation | 79,624,692 | |
| Median | 167,000,000 | |
| Standard Deviation | 93,740,107 | |
| Sample Variance | 8787.2T | |
| Range | 303.9M | |
| R-Value | 0.99 | |
| Mean Square Error | 216.4T | |
| R-Squared | 0.98 | |
| Slope | 18,347,718 | |
| Total Sum of Squares | 140595.3T |
Illumina Current Deferred Revenue History
About Illumina Financial Statements
Illumina investors utilize fundamental indicators, such as Current Deferred Revenue, to predict how Illumina Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 299 M | 313.9 M |
Pair Trading with Illumina
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Illumina position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Illumina will appreciate offsetting losses from the drop in the long position's value.Moving against Illumina Stock
| 0.77 | CTE | Cryosite Earnings Call This Week | PairCorr |
| 0.38 | CDT | Conduit Pharmaceuticals | PairCorr |
| 0.36 | OSL | Oncosil Medical | PairCorr |
The ability to find closely correlated positions to Illumina could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Illumina when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Illumina - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Illumina to buy it.
The correlation of Illumina is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Illumina moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Illumina moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Illumina can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Illumina Correlation against competitors. To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Will Life Sciences Tools & Services sector continue expanding? Could Illumina diversify its offerings? Factors like these will boost the valuation of Illumina. Market participants price Illumina higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Illumina data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.864 | Earnings Share 5.46 | Revenue Per Share | Quarterly Revenue Growth 0.05 | Return On Assets |
Illumina's market price often diverges from its book value, the accounting figure shown on Illumina's balance sheet. Smart investors calculate Illumina's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Illumina's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.